Filed: 8/13/2026ACC: 0001766721-26-000003
📋 What this filing means
AISLING CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 14 equity positions with a total reported market value of $471.62M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
14
Positions
$471.62M
Total AUM (reported)
13.94M
Total Shares
Allocation by class
COM$440.83M93.5%
SPONSORED ADS$20.27M4.3%
COM NEW$8.24M1.7%
CL A NEW$1.88M0.4%
COM CL A$404.0K0.1%
Portfolio Concentration
Top 3$408.27M86.6%
4–10$58.44M12.4%
11–25$4.91M1.0%
Top 3 weight
86.6%
Top 10 weight
99.0%
Voting Authority Distribution
Total shares with voting rights: 13.94M
Sole
Full voting authority
13.94M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole14
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings14
Rows:
BRIDGEBIO PHARMA INC
SOLEShares4.59M
TypeSH
Market value$341.83M
72.48%
Sole
4.59M
Shared
0.00
None
0.00
MONTE ROSA THERAPEUTICS INC
SOLEShares1.56M
TypeSH
Market value$37.65M
7.98%
Sole
1.56M
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares1.32M
TypeSH
Market value$28.79M
6.10%
Sole
1.32M
Shared
0.00
None
0.00
COMPASS PATHWAYS PLC
SOLEShares1.43M
TypeSH
Market value$20.27M
4.30%
Sole
1.43M
Shared
0.00
None
0.00
BICARA THERAPEUTICS INC
SOLEShares568.92K
TypeSH
Market value$16.89M
3.58%
Sole
568.92K
Shared
0.00
None
0.00
BRIDGEBIO ONCOLOGY THERAPEUT
SOLEShares1.02M
TypeSH
Market value$7.76M
1.64%
Sole
1.02M
Shared
0.00
None
0.00
SCHOLAR ROCK HLDG CORP
SOLEShares77.03K
TypeSH
Market value$4.24M
0.90%
Sole
77.03K
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares108K
TypeSH
Market value$3.97M
0.84%
Sole
108K
Shared
0.00
None
0.00
BIOMEA FUSION INC
SOLEShares2.05M
TypeSH
Market value$3.01M
0.64%
Sole
2.05M
Shared
0.00
None
0.00
ACLARIS THERAPEUTICS INC
SOLEShares434.45K
TypeSH
Market value$2.30M
0.49%
Sole
434.45K
Shared
0.00
None
0.00
EUPRAXIA PHARMACEUTICALS INC
SOLEShares325K
TypeSH
Market value$2.15M
0.46%
Sole
325K
Shared
0.00
None
0.00
VTV THERAPEUTICS INC
SOLEShares50K
TypeSH
Market value$1.88M
0.40%
Sole
50K
Shared
0.00
None
0.00
MARKER THERAPEUTICS INC
SOLEShares325.37K
TypeSH
Market value$478.3K
0.10%
Sole
325.37K
Shared
0.00
None
0.00
ONKURE THERAPEUTICS INC
SOLEShares88.61K
TypeSH
Market value$404.0K
0.09%
Sole
88.61K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BRIDGEBIO PHARMA INCSOLE | COM | 4.59M | SH | $341.83M 72.48% | 4.59M | 0.00 | 0.00 |
MONTE ROSA THERAPEUTICS INCSOLE | COM | 1.56M | SH | $37.65M 7.98% | 1.56M | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 1.32M | SH | $28.79M 6.10% | 1.32M | 0.00 | 0.00 |
COMPASS PATHWAYS PLCSOLE | SPONSORED ADS | 1.43M | SH | $20.27M 4.30% | 1.43M | 0.00 | 0.00 |
BICARA THERAPEUTICS INCSOLE | COM | 568.92K | SH | $16.89M 3.58% | 568.92K | 0.00 | 0.00 |
BRIDGEBIO ONCOLOGY THERAPEUTSOLE | COM NEW | 1.02M | SH | $7.76M 1.64% | 1.02M | 0.00 | 0.00 |
SCHOLAR ROCK HLDG CORPSOLE | COM | 77.03K | SH | $4.24M 0.90% | 77.03K | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 108K | SH | $3.97M 0.84% | 108K | 0.00 | 0.00 |
BIOMEA FUSION INCSOLE | COM | 2.05M | SH | $3.01M 0.64% | 2.05M | 0.00 | 0.00 |
ACLARIS THERAPEUTICS INCSOLE | COM | 434.45K | SH | $2.30M 0.49% | 434.45K | 0.00 | 0.00 |
EUPRAXIA PHARMACEUTICALS INCSOLE | COM | 325K | SH | $2.15M 0.46% | 325K | 0.00 | 0.00 |
VTV THERAPEUTICS INCSOLE | CL A NEW | 50K | SH | $1.88M 0.40% | 50K | 0.00 | 0.00 |
MARKER THERAPEUTICS INCSOLE | COM NEW | 325.37K | SH | $478.3K 0.10% | 325.37K | 0.00 | 0.00 |
ONKURE THERAPEUTICS INCSOLE | COM CL A | 88.61K | SH | $404.0K 0.09% | 88.61K | 0.00 | 0.00 |